Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. [electronic resource]
Producer: 19950602Description: 546-54 p. digitalISSN:- 0007-1048
- Adolescent
- Adult
- Aged
- Base Sequence
- Female
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Interferon-alpha -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- genetics
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative -- genetics
- Male
- Middle Aged
- Molecular Sequence Data
- Oncogene Proteins -- genetics
- Prognosis
- Prospective Studies
- Protein-Tyrosine Kinases
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-bcr
- RNA Splicing
- RNA, Messenger -- genetics
- RNA, Neoplasm -- genetics
- Survival Rate
- Time Factors
- Transcription, Genetic -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.